|
National Stock Number(NSN): 6505-01-274-8519 (6505012748519, 012748519)
| NIIN: |
01-274-8519 |
Item Name: |
AZTREONAM FOR INJECTION |
INC: |
49650
|
| FSC: |
6505
|
Assignment Date: |
Mar-15-1988 |
CRIT: |
X |
IIG: |
49650 |
| ISC: |
2 |
Date Standardized: |
Sep-04-1988 |
HMIC: |
P |
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Dec-19-2024 |
PMIC: |
A |
FIIG: |
A34300 |
| ESD: |
|
Schedule B: |
3004.90.9260 |
DEMIL: |
A |
DEMIL INT: |
|
| TIIC: |
1 |
Originator: |
KX |
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
8-0010 |
64616
|
DEFENSE MEDICAL STANDARDIZATION BOARD |
H |
5 |
1 |
|
|
|
|
|
|
|
|
|
AZACTAM |
78473
|
SQUIBB E R AND SONS INC WORLD HQ |
H |
5 |
1 |
|
|
|
|
|
|
|
|
|
NDC00003-2502-15 |
78473
|
SQUIBB E R AND SONS INC WORLD HQ |
H |
5 |
9 |
|
|
|
|
|
|
|
|
|
NDC00003-2560-15 |
78473
|
SQUIBB E R AND SONS INC WORLD HQ |
H |
3 |
2 |
|
|
|
|
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DA |
S9M |
Y |
|
M |
U |
1 |
A |
$209.44 |
PG |
|
C2201X- |
Dec-01-1995 |
H |
| DF |
S9M |
Y |
|
M |
U |
1 |
F |
$209.44 |
PG |
|
------- |
Dec-01-1995 |
H |
| DN |
S9M |
Y |
|
M |
U |
1 |
N |
$209.44 |
PG |
|
9L----- |
Dec-01-1995 |
H |
| DS |
S9M |
Y |
|
M |
U |
1 |
D |
$209.44 |
PG |
|
------- |
Dec-01-1995 |
H |
| VA |
JVS |
I |
|
M |
U |
1 |
V |
$0.00 |
PG |
|
------- |
Apr-01-1989 |
H |
| MOEC |
PC |
Phrase |
QPA |
UOM |
OOU |
JTC |
| DA |
V |
DISCONTINUED W/O REPLACEMENT |
000 |
|
|
|
| DF |
V |
DISCONTINUED W/O REPLACEMENT |
000 |
|
|
|
| DN |
V |
DISCONTINUED W/O REPLACEMENT |
000 |
|
|
|
| DS |
V |
DISCONTINUED W/O REPLACEMENT |
000 |
|
|
|
| VA |
K |
U/I CONTAINS 25 EA |
000 |
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AGXW |
PHYSICAL FORM |
FREEZE-DRIED POWDER |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
1.000 GRAMS AZTREONAM ACTIVE INGREDIENT |
| CQCT |
PRIMARY CONTAINER TYPE |
VIAL |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
1.000 GRAMS OF ACTIVE INGREDIENT |
| CSCW |
TOTAL PRIMARY CONTAINER QUANTITY |
25 |
| CSGS |
ADMINISTRATION |
INTRAMUSCULAR OR INTRAVENOUS |
| FEAT |
SPECIAL FEATURES |
CONTAINS 780 MG L-ARGININE PER GRAM OF AZTREONAM |
| MDES |
MEDICAL DESIGNATION AND GRADE |
UNITED STATES PHARMACOPEIA |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| V542 |
|
Apr-01-1991 |
0 |
0 |
|
|
54 |
54 |
| Description: |
DRUGS/MEDICINES/VITAMINS NOI |
Originating Activity: |
KX |
| Hazardous Material: |
|
National Motor Freight Classification Number: |
058770 |
| Less Than One Truckload: |
W |
NMFC Sub-Item: |
Z |
| Uniform Freight Classification Number: |
33400 |
Rail Variance Code: |
|
| Less Than One Carload: |
|
Water Commodity Code: |
532 |
| Type of Cargo Code: |
Z |
Special Handling Code: |
9 |
| Air Commodity Special Handling Code: |
MZ |
Air Dimension Code: |
A |
|